SNX3 Knockout HCT 116 Cell Line
Cat.No.:
EDC08246
Species:
Human
Cell Name:
HCT 116
Gene:
SNX3
Gene ID:
8724
Size:
1×10⁶cells
SNX3 Knockout HCT116 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08246 |
|---|---|
| Product Name | SNX3 Knockout HCT116 Cell Line |
| Species | Human |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene ID | |
| Gene | SNX3 |
| Gene Synonyms | Grd19|MCOPS8|SDP3 |
| Summary |
This gene encodes a member of the sorting nexin family. Members of this family contain a phox (PX) domain, which is a phosphoinositide binding domain, and are involved in intracellular trafficking. This protein does not contain a coiled coil region, like most family members. This protein interacts with phosphatidylinositol-3-phosphate, and is involved in protein trafficking. A pseudogene of this gene is present on the sex chromosomes. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
|
| Associated Diseases | Colorectal Carcinoma |
| Digestion Time | 3 min |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 90% FBS/complete culture medium+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SNX3 function, SNX3 Knockout HCT 116 Cell Line or SNX3 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SNX3's role in retromer-mediated endosome-to-Golgi retrieval or its functions in Wnt secretion (Wntless trafficking). The Knockout line is the standard tool for asking whether SNX3 is required for these endosomal sorting events — particularly relevant in HCT 116 where Wnt pathway dysregulation is a feature of colorectal cancer biology. Overexpression is useful for testing SNX3 sufficiency in retromer cargo recruitment.
For SNX3 research, the EDITGENE Knockout in HCT 116 provides a colorectal cancer-relevant context for studying retromer-dependent Wnt secretion — Wntless/GPR177 cycling through endosomes requires SNX3-retromer for proper trafficking. Rescue with wild-type or PX-domain-mutant SNX3 (phosphatidylinositol 3-phosphate-binding-deficient) enables endosomal membrane targeting versus cargo recognition dissection.
What are the application scenarios for this model?
Primary applications:
• Retromer cargo trafficking: Wntless/GPR177 localization and Wnt secretion assays to assess SNX3-retromer-dependent cargo cycling.
• Endosomal sorting analysis: imaging-based analysis of late endosome morphology and TGN-endosome traffic in the absence of SNX3.
• Wnt pathway readouts: Wnt secretion assays and TCF reporter activity in conditioned media or co-culture systems.
• Cancer phenotype assays: proliferation and Wnt-dependent gene expression in colorectal cancer context.
EDITGENE recommends this model for researchers investigating endosomal sorting, retromer biology, and Wnt secretion mechanisms in colorectal cancer.
Is this SNX3 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. SNX3 rescue experiments require attention to phosphoinositide-dependent membrane targeting:
• Construct design: use a codon-modified SNX3 sequence with a small C-terminal tag (FLAG, HA, GFP for imaging). SNX3 is small (~162 amino acids) and consists primarily of a PX domain.
• PX domain-mutant rescue: PI3P-binding-deficient mutations (e.g., R57E) abolish endosomal membrane targeting and serve as the standard specificity control.
• Cargo-binding-deficient rescue: where mapped, mutations affecting SNX3's interaction with retromer cargo (Wntless) enable functional dissection.
• Functional readout: rescue should restore Wntless trafficking and Wnt secretion in HCT 116.
HCT 116 transduces efficiently with lentivirus; the MSI-high colorectal cancer background should be considered when interpreting Wnt pathway readouts.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download